The combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis

Sadeleştirilmiş öğe sayfası
dc.contributor.authorMutlu, Hasan
dc.contributor.authorBuyukcelik, Abdullah
dc.date.accessioned2025-10-16T15:30:42Z
dc.date.issued2015
dc.identifier.doi10.1177/1078155214531514
dc.identifier.otherWOS:000357297600012
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8937
dc.publisherSAGE PUBLICATIONS LTD
dc.sourceJOURNAL OF ONCOLOGY PHARMACY PRACTICE
dc.titleThe combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS